Delivery Order SPE2DB22D2007-SPE2DB25FJ2NA
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency (DLA) for the supply of Prevnar 20 vaccines in 0.5mL syringes. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, valued at $10,289.11, is scheduled for completion by April 23, 2025, and represents a non-set-aside, competitively awarded contract. The award was executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract utilizes firm fixed price terms with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp was awarded a $5,560.53 delivery order by the Defense Logistics Agency for Prevnar 20 vaccine in syringe form (0.5mL), with an ultimate completion date of August 27, 2025. The contract was awarded on August 26, 2025, using firm fixed price terms with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a primary distribution center for its pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,989.90 by the Defense Logistics Agency (DLA) on July 14, 2025. The order is for Prevnar 20 vaccine in 0.5ml syringes and will be completed by July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Prevnar 20 Syringe 0.5ML vaccines. This competitively awarded, firm fixed-price delivery order has a ceiling value of $73,941.30 and an ultimate completion date of July 23, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for PREVNAR 20 Syringe 0.5ML with a ceiling value of $7,179.67. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2NADelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $29,835.95 by the Defense Logistics Agency (DLA) on June 25, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen regularly supplies vaccines, medications, and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. The Prevnar 20 vaccine delivery fulfills the Department of Defense's ongoing need for pneumococcal immunization products to support military readiness and troop health across the federal healthcare system. AmerisourceBergen's competitive award history and extensive federal contract portfolio demonstrate its capability to meet federal procurement requirements for time-sensitive medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 6/25/25 |